Clinical Trial Update: Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating a combination drug therapy for untreated obstructive sleep apnea has completed enrollment and posted results in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Combination therapy (name not disclosed)

Snippet

Sponsor: University of California, San Diego | Conditions: OSA, Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED | Results posted: 2024-05-02